ArticleBMC research notes2026
Phenolic profile, antioxidant and antibacterial activities of Balanites aegyptiaca fruit peel.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Balanites aegyptiaca fruit possesses bioactive properties, which may be attributed to its phenolic compounds. However, identifying these phenolic compounds has become increasingly relevant to understanding such activities. Generally, fruit peel contains high content of phenolic compounds compared with flesh. Therefore, this study aimed to identify the profile of phenolic compounds in B. aegyptiaca fruit peel extract (BAFPE) and evaluate their antioxidant and antibacterial activities.
resultsIn this study, the great phenolic and flavonoid contents of 1040 mg GAE/100 g DW and 287 mg CE/100 g DW were detected in BAFPE, respectively. The main phenolic compounds identified by the HPLC analysis of BAFPE were gallic acid, apigenin-7-glucoside, rutin, quercetin, and catechin. The antioxidant activity of BAFPE was assessed by 2,2- diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azino-bis-[3-ethyl-benzothiazoline]-6-sulfonic acid (ABTS), ferric reducing antioxidant power (FRAP), phosphomolybdenum complex (PMC) and reducing power (RP) assays. The BAFPE showed an efficient antibacterial activity against five human pathogenic bacterial strains with low minimum inhibition concentration (MIC) values. After 8 to 10 h, every examined bacterial strain was entirely dead in the time-killing curves. The correlation of phenolic compounds and antibacterial activity has been discussed. These findings demonstrated that BAFPE can serve as the free radicals neutralizer and antibacterial agent.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.